RPT-New wave of drugs poised to shake up glaucoma treatment

WASHINGTON, Feb 10 (Reuters) - For the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as several young companies look to shake up the $5.6 billion global market